Cetuximab versus methotrexate in first-line treatment of older, frail patients with inoperable recurrent or metastatic head and neck cancer (ELAN UNFIT): a randomised, open-label, phase 3 trial

Autor: Guigay, Joël *, Ortholan, Cécile, Vansteene, Damien, Cupissol, Didier, Even, Caroline, Kaminsky, Marie-Christine, Sire, Christian, Blot, Emmanuel, Debourdeau, Philippe, Bozec, Laurence, Saada-Bouzid, Esma, Fayette, Jérôme, Dalloz, Pierre, Pointreau, Yoann, Caer, Hervé Le, Falandry, Claire, Digue, Laurence, Braccini, Antoine, Lopez, Stéphane, Guillet, Pierre, Michel, Cécile, Cheurfa, Nadir, Schwob, Dominique, Bourhis, Jean, Mertens, Cécile, Aupérin, Anne
Zdroj: In The Lancet Healthy Longevity March 2024 5(3):e182-e193
Databáze: ScienceDirect